Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome2008 · 75 citations
2. 2Clinical Outcome of HIV-Infected Patients with Discordant Virological and Immunological Response to Antiretroviral Therapy2010 · 74 citations
3. 3Immunologic, Virologic, and Clinical Consequences of Episodes of Transient Viremia During Suppressive Combination Antiretroviral Therapy2008 · 34 citations
4. 4CD4 cell count changes in individuals with counts above 500 cells/mm3 and viral loads below 50 copies/ml on antiretroviral therapy2002 · 20 citations
5. 5Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in <scp>HIV</scp>‐1‐infected treatment‐naïve patients in the <scp>ARTEMIS</scp> trial2012 · 159 citations